Management and prevention of recurrent hemarthrosis in patients with hemophilia
AL Dunn - Current opinion in hematology, 2005 - journals.lww.com
Current opinion in hematology, 2005•journals.lww.com
As hemophilia care evolves, current on-demand and prophylactic regimens will be
optimized. Synovectomy will likely play a larger role in the control of synovitis, and validated
quality-of-life scores will allow more consistent communication of outcomes. New
understanding of the molecular mechanisms of joint destruction will pave the way for new
therapeutic options for persons with hemophilia.
optimized. Synovectomy will likely play a larger role in the control of synovitis, and validated
quality-of-life scores will allow more consistent communication of outcomes. New
understanding of the molecular mechanisms of joint destruction will pave the way for new
therapeutic options for persons with hemophilia.
Summary
As hemophilia care evolves, current on-demand and prophylactic regimens will be optimized. Synovectomy will likely play a larger role in the control of synovitis, and validated quality-of-life scores will allow more consistent communication of outcomes. New understanding of the molecular mechanisms of joint destruction will pave the way for new therapeutic options for persons with hemophilia.
Lippincott Williams & Wilkins